⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 3, 2024Open Access

Figure S2 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg Simone Maarup Arianna Draghi Annie Borch Sille Hendriksen Filip Mundt Vilde Pedersen Matthias Mann Ib Jarle Christensen Jane Skjøth-Ramussen Christina W. Yde Bjarne Winther Kristensen Hans Skovgaard Poulsen Benedikte Hasselbalch Inge Marie Svane Ulrik Lassen Sine Reker Hadrup

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Flow cytometry analysis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Skadborg et al. (2024) studied this question.

synapsesocial.com/papers/68e598e8b6db64358753397c https://doi.org/10.1158/2326-6066.26926024.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S6 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways2024
2Figure S12 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways2024
3Figure S13 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways2024
4Figure S11 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways2024
5Figure S10 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways2024